Disclosures for "Imaging CD8+ T Cells in Patients With Inclusion Body Myositis (IBM) Treated With Ulviprubart"
-
Dr. Farwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abcuro. The institution of Dr. Farwell has received research support from ImaginAb.
-
Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Henderson has received publishing royalties from a publication relating to health care.
-
Dr. Needham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for teva. Dr. Needham has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abcuro. Dr. Needham has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi aventis.
-
Dr. Soler-Ferran has received personal compensation for serving as an employee of Abcuro. Dr. Soler-Ferran has stock in Pfizer.
-
Dr. Wilkins has received personal compensation for serving as an employee of Abcuro.